Advertisement

Abstract

Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.

Get full access to this article

View all available purchase options and get full access to this article.

References

CELL 72: 971 (1993).
CELL 78: 23 (1994).
AMBROSE, C.M., STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT, SOMATIC CELL AND MOLECULAR GENETICS 20: 27 (1994).
BARNES, G.T., MOUSE HUNTINGTONS-DISEASE GENE HOMOLOG (HDH), SOMATIC CELL AND MOLECULAR GENETICS 20: 87 (1994).
BLUM, M, GASTRULATION IN THE MOUSE - THE ROLE OF THE HOMEOBOX GENE GOOSECOID, CELL 69: 1097 (1992).
CONLON, R.A., DETECTION OF MESSENGER-RNA BY IN-SITU HYBRIDIZATION TO POSTIMPLANTATION EMBRYO WHOLE MOUNTS, GUIDE TO TECHNIQUES IN MOUSE DEVELOPMENT 225: 373 (1993).
COPP, A.J., DEATH BEFORE BIRTH - CLUES FROM GENE KNOCKOUTS AND MUTATIONS, TRENDS IN GENETICS 11: 87 (1995).
DIFIGLIA, M, HUNTINGTIN IS A CYTOPLASMIC PROTEIN ASSOCIATED WITH VESICLES IN HUMAN AND RAT-BRAIN NEURONS, NEURON 14: 1075 (1995).
Folstein, S. E., Huntington's Disease. A Disorder of Families (1989).
GUSELLA, J.F., MOLECULAR-GENETICS OF HUNTINGTONS-DISEASE, ARCHIVES OF NEUROLOGY 50: 1157 (1993).
GUSELLA, J.F., HUNTINGTONS-DISEASE, SEMINARS IN CELL BIOLOGY 6: 21 (1995).
HERRMANN, B.G., EXPRESSION PATTERN OF THE BRACHYURY GENE IN WHOLE-MOUNT TWIS/TWIS MUTANT EMBRYOS, DEVELOPMENT 113: 913 (1991).
JOU, Y.S., EVIDENCE FROM ANTIBODY STUDIES THAT THE CAG REPEAT IN THE HUNTINGTON DISEASE GENE IS EXPRESSED IN THE PROTEIN, HUMAN MOLECULAR GENETICS 4: 465 (1995).
Joyner, A. L., Gene Targeting: A Practical Approach (1993).
LIN, B, SEQUENCE OF THE MURINE HUNTINGTON DISEASE GENE - EVIDENCE FOR CONSERVATION, AND POLYMORPHISM IN A TRIPLET (CCG) REPEAT ALTERNATE SPLICING, HUMAN MOLECULAR GENETICS 3: 85 (1994).
MARTIN, J.B., HUNTINGTONS-DISEASE - PATHOGENESIS AND MANAGEMENT, NEW ENGLAND JOURNAL OF MEDICINE 315: 1267 (1986).
MONAGHAN, A.P., POSTIMPLANTATION EXPRESSION PATTERNS INDICATE A ROLE FOR THE MOUSE FORKHEAD/HNF-3 ALPHA,BETA AND GAMMA GENES IN DETERMINATION OF THE DEFINITIVE ENDODERM, CHORDAMESODERM AND NEUROECTODERM, DEVELOPMENT 119: 567 (1993).
MORTENSEN, R.M., PRODUCTION OF HOMOZYGOUS MUTANT ES CELLS WITH A SINGLE TARGETING CONSTRUCT, MOLECULAR AND CELLULAR BIOLOGY 12: 2391 (1992).
Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
NAGY, A, DERIVATION OF COMPLETELY CELL CULTURE-DERIVED MICE FROM EARLY-PASSAGE EMBRYONIC STEM-CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8424 (1993).
NASIR, J, TARGETED DISRUPTION OF THE HUNTINGTONS-DISEASE GENE RESULTS IN EMBRYONIC LETHALITY AND BEHAVIORAL AND MORPHOLOGICAL-CHANGES IN HETEROZYGOTES, CELL 81: 811 (1995).
PERSICHETTI, F, NORMAL AND EXPANDED HUNTINGTONS-DISEASE GENE ALLELES PRODUCE DISTINGUISHABLE PROTEINS DUE TO TRANSLATION ACROSS THE CAG REPEAT, MOLECULAR MEDICINE 1: 374 (1995).
PIERETTI, M, ABSENCE OF EXPRESSION OF THE FMR-1 GENE IN FRAGILE-X SYNDROME, CELL 66: 817 (1991).
SHARP, A.H., WIDESPREAD EXPRESSION OF HUNTINGTONS-DISEASE GENE (IT15) PROTEIN PRODUCT, NEURON 14: 1065 (1995).
SUTCLIFFE, J.S., HUM MOL GENET 1: 397 (1992).
TROTTIER, Y, CELLULAR-LOCALIZATION OF THE HUNTINGTONS-DISEASE PROTEIN AND DISCRIMINATION OF THE NORMAL AND MUTATED FORM, NATURE GENETICS 10: 104 (1995).
TYBULEWICZ, VLJ, NEONATAL LETHALITY AND LYMPHOPENIA IN MICE WITH A HOMOZYGOUS DISRUPTION OF THE C-ABL PROTOONCOGENE, CELL 65: 1153 (1991).
VERKERK, AJMH, IDENTIFICATION OF A GENE (FMR-1) CONTAINING A CGG REPEAT COINCIDENT WITH A BREAKPOINT CLUSTER REGION EXHIBITING LENGTH VARIATION IN FRAGILE-X SYNDROME, CELL 65: 905 (1991).
VONSATTEL, J.P., NEUROPATHOLOGICAL CLASSIFICATION OF HUNTINGTONS-DISEASE, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 44: 559 (1985).
WILLEMS, P.J., DYNAMIC MUTATIONS HIT DOUBLE FIGURES, NATURE GENETICS 8: 213 (1994).
Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 269 | Issue 5222
21 July 1995

Submission history

Published in print: 21 July 1995

Permissions

Request permissions for this article.

Authors

Affiliations

Mabel P. Duyao
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Anna B. Auerbach
Division of Molecular and Developmental Biology, Mount Sinai Hospital, Toronto M5G1X5, Canada.
Angela Ryan
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Francesca Persichetti
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Glenn T. Barnes
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Sandra M. McNeil
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Pei Ge
Laboratory for Molecular Neuropathology, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Jean-Paul Vonsattel
Laboratory for Molecular Neuropathology, Massachusetts General Hospital, Charlestown, MA 02129, USA.
James F. Gusella
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Alexandra L. Joyner
Division of Molecular and Developmental Biology, Mount Sinai Hospital, Toronto M5G1X5, Canada.
Marcy E. MacDonald*
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.

Notes

*
To whom correspondence should be addressed.

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease, Science Signaling, 7, 349, (ra103-ra103), (2021)./doi/10.1126/scisignal.2005633
    Abstract
  2. Huntington’s disease alters human neurodevelopment, Science, 369, 6505, (787-793), (2021)./doi/10.1126/science.aax3338
    Abstract
  3. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease, Science, 293, 5529, (493-498), (2001)./doi/10.1126/science.1059581
    Abstract
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media